StockData
QIAGEN N.V. logo

QIAGEN N.V. (QGEN) stock

QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 10/30
$49.75−0.06 (-0.12%)

Close on Nov 17, 2026Market cap $10.79BP/E 25.6Yield 0.50%

How the market prices Qiagen

Each ratio against its own distribution since 2016, from month-end prices and the figures reported at the time

Qiagen trades at 25.7× its earnings, against a median of 38.1× since 2016 — on the cheap side of its own range.

The shaded bar covers the 5th to 95th percentile of month-end values since 2016, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.

Price to earnings since 2016

Median 38.1×, today 25.7×

What Qiagen keeps of every dollar

Trailing twelve months, from revenue down to net income. Grey columns are what comes out.

Margins against the industry

Gross margin62.2%vs 52.8%
Operating margin22.3%vs -42.9%
EBITDA margin31.6%vs -29.3%
Pretax margin23.5%vs -13.0%
Net margin20.3%vs -39.9%
Free cash flow margin21.7%vs -9.41%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it earns on the capital it uses

Trailing twelve months over average capital

Return on equity11.6%vs -53.5%
Return on assets7.10%vs -40.7%
Return on invested capital9.92%vs -32.4%
Return on capital employed8.07%vs -38.7%

How hard the assets work

Revenue per dollar of assets0.35vs 0.39
Inventory turns a year2.72vs 2.68
Revenue per employee$366.67Kvs $405.05K
Profit per employee$74.54Kvs -$704.12K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How fast it is growing

Trailing twelve months against a year earlier, and the compound annual rate over three and five fiscal years

Last 12 months3-year, a year5-year, a yearIndustry median

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Borrowings exceed cash by $555.51M, or 0.8 times a year of EBITDA. That is 4.9% of the $11.36B it would cost to buy the business outright.

Total debt$1.65B
Cash and short-term investments$1.10B
EBITDA, trailing twelve months$659.60M
Free cash flow, trailing twelve months$453.28M

Leverage and liquidity

Debt to equity0.44vs 0.50
Debt to EBITDA2.51vs 3.42
Net debt to EBITDA0.84vs 2.33
Debt to free cash flow3.65vs 4.83
Current ratio3.90vs 3.30
Quick ratio2.93vs 2.38

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Altman Z-Score

Five ratios that together predicted bankruptcy within two years.

4.06
DistressGrey zoneSafe

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

8 of 9 tests passed

Beneish M-Score

Eight variables that flag accounts shaped to look better than they are.

-2.60
No flagManipulation risk

Price against two rules of thumb

Graham's number and Lynch's fair value, both derived from current earnings.

Graham $27.57Price $49.81

What comes back to shareholders

Trailing twelve months against the market value at the latest close

Earnings yield3.93%vs -22.5%
Free cash flow yield4.20%vs -9.38%
Dividend yield0.50%vs 1.89%
Buyback yield2.59%vs -0.65%
Shareholder yield3.09%vs 0.00%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Dividends out of earnings

13%
Room to spareMost of itMore than it makes

Dividends out of free cash flow

12%
Room to spareMost of itMore than it makes

How the shares have traded

Total return includes reinvested dividends, to the close on Nov 17, 2026

$32.5352-week low52-week high$57.81
200-day50-day$49.8120-day

The close sits 68% of the way up the 52-week range, 13.8% below the high.

Relative strength index, 14 days

How much of the recent move has been upward. Extremes are where traders look for a turn.

60
OversoldNeutralOverbought

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

QGENS&P 500
PeriodQGENS&P 500DifferenceQGEN per yearS&P 500 per year
1 month+7.8%-4.0%+11.9 pts
3 months+16.8%-5.0%+21.8 pts
Year to date+6.0%+8.2%−2.2 pts
1 year+8.1%+11.2%−3.2 pts
3 years+25.5%+68.5%−43.0 pts+7.9%+19.0%
5 years-9.8%+67.3%−77.1 pts-2.0%+10.8%
10 years+83.3%+291.6%−208.3 pts+6.2%+14.6%

How much it moves

Volatility, 1 year35.4%vs 80.4%
Volume against its 90-day average0.50vs 0.86

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

6M QGEN shares were sold short on Oct 30, 2026, down 11.1% from the previous report, or 2.95% of the shares available to trade. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 31.7% of the volume reported to FINRA was short selling.

Shares sold shortDays to cover
Short interest as a share of the float2.95%vs 8.91%
Short interest as a share of all shares2.95%vs 6.30%
Days of volume to buy it back1.00vs 5.16

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20266,404,422-11.1%8,673,7601.0
Oct 15, 20267,202,427-6.2%2,189,0083.3
Sep 30, 20267,682,054+0.2%2,159,9863.6
Sep 15, 20267,664,091+2.1%1,700,2604.5
Aug 31, 20267,509,104-25.9%3,399,7382.2
Aug 14, 202610,140,064+23.2%3,265,6163.1
Jul 31, 20268,232,939+3.8%2,081,5094.0
Jul 15, 20267,929,408+20.0%3,811,9842.1
Jun 30, 20266,610,179-13.0%2,751,7162.4
Jun 15, 20267,599,057+32.1%2,281,0083.3
May 29, 20265,751,359-36.7%2,066,6942.8
May 15, 20269,080,139+42.9%2,279,5894.0

Every measure, in full

109 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
Jul 7, 2026
Fundamentals through
Dec 31, 2025
Share price as of
Nov 16, 2026

Valuation ratiosIndustry

Market Cap
$10.80B
$261.21M
Enterprise Value
$11.36B
$135.05M
PE Ratio
25.68
23.48
PS Ratio
5.17
3.76
PB Ratio
2.86
2.01
P/TBV Ratio
15.63
2.23
P/FCF Ratio
23.84
18.76
P/OCF Ratio
16.51
13.21

Enterprise valuationIndustry

EV / Sales
5.44
2.44
EV / EBITDA
17.22
16.15
EV / EBIT
24.39
18.75
EV / FCF
25.06
21.73

Share statisticsIndustry

Shares Change (YoY)
-2.60%
10.9%
Float
217M
49M
Shares Held by Insiders
0.00%
11.2%
Shares Held by Institutions
67.4%
56.2%

Short sellingIndustry

Short Interest
6M
–
Short Interest Change
-11.1%
-0.81%
Short % of Float
2.95%
8.91%
Short % of Shares Outstanding
2.95%
6.30%
Days to Cover
1.00
5.16

Stock price statisticsIndustry

52-Week High
$57.81
–
52-Week Low
$32.53
–
20-Day Moving Average
$50.24
–
50-Day Moving Average
$46.63
–
200-Day Moving Average
$42.43
–
Average True Range (14)
$0.65
–
Price Change (1 Week)
-1.46%
-7.62%
Price Change (1 Month)
7.98%
-4.88%
Price Change (3 Months)
17.7%
-24.2%
Price Change (6 Months)
47.5%
-21.7%
Price Change (YTD)
5.22%
-26.2%
Price Change (1 Year)
5.98%
-22.5%
Price Change (3 Years)
20.3%
-31.7%
Price Change (5 Years)
-15.5%
-77.9%
Price Change (10 Years)
69.9%
-66.0%
Average Volume (10 Days)
4M
–
Average Volume (20 Days)
7M
–
Average Volume (90 Days)
3M
–
Relative Volume
0.50
0.86
Relative Strength Index (14)
59.5
40.8
Volatility (1 Year)
35.4%
80.4%

MarginsIndustry

Gross Margin
62.2%
52.8%
Operating Margin
22.3%
-42.9%
Pretax Margin
23.5%
-13.0%
Profit Margin
20.3%
-39.9%
EBITDA Margin
31.6%
-29.3%
FCF Margin
21.7%
-9.41%

Returns on capitalIndustry

Return on Equity (ROE)
11.6%
-53.5%
Return on Assets (ROA)
7.10%
-40.7%
Return on Invested Capital (ROIC)
9.92%
-32.4%
Return on Capital Employed (ROCE)
8.07%
-38.7%

Financial positionIndustry

Current Ratio
3.90
3.30
Quick Ratio
2.93
2.38
Debt / Equity
0.44
0.50
Debt / EBITDA
2.51
3.42
Debt / FCF
3.65
4.83
Net Debt / EBITDA
0.84
2.33
Interest Coverage
14.01
-6.20

GrowthIndustry

Revenue Growth (YoY)
5.65%
5.71%
Net Income Growth (YoY)
408.3%
-31.1%
EPS Growth (YoY)
424.3%
-25.8%
FCF Growth (YoY)
-10.5%
3.26%
Revenue Growth (3Y CAGR)
-0.81%
2.25%
Revenue Growth (5Y CAGR)
2.25%
6.41%
EPS Growth (3Y CAGR)
1.78%
-0.17%
EPS Growth (5Y CAGR)
4.86%
3.69%

EfficiencyIndustry

Asset Turnover
0.35
0.39
Inventory Turnover
2.72
2.68
Revenue Per Employee
$366.67K
$405.05K
Profits Per Employee
$74.54K
-$704.12K
Employee Count
5,700
75

Income statement (TTM)Industry

Revenue
$2.09B
$58.79M
Gross Profit
$1.30B
$103.58M
Operating Income
$465.85M
-$21.49M
Pretax Income
$490.27M
-$14.83M
Net Income
$424.88M
-$22.47M
EBITDA
$659.60M
-$17.14M
EPS (Diluted)
$1.94
-$0.83

Balance sheetIndustry

Total Debt
$1.65B
$114.91M
Net Cash (Debt)
-$555.51M
$15.35M
Net Cash Per Share
-$2.56
$0.71
Equity (Book Value)
$3.78B
$49.84M
Book Value Per Share
$17.42
$1.45
Tangible Book Value
$691.07M
$23.91M
Working Capital
$1.48B
$74.41M

Cash flow (TTM)Industry

Operating Cash Flow
$654.33M
-$12.17M
Capital Expenditures
-$201.05M
-$1.03M
Free Cash Flow
$453.28M
-$20.28M
FCF Per Share
$2.09
-$0.42

Dividends and yieldsIndustry

Earnings Yield
3.93%
-22.5%
FCF Yield
4.20%
-9.38%
Dividend Yield
0.50%
1.89%
Buyback Yield
2.59%
-0.65%
Shareholder Yield
3.09%
0.00%
Dividend Per Share
$0.25
$0.83
Years of Dividend Growth
0
0
Payout Ratio
12.8%
46.8%
FCF Payout Ratio
12.0%
44.4%

Taxes and interestIndustry

Interest Expense
$33.26M
$3.07M
Income Tax
$65.39M
$80.43K
Effective Tax Rate
13.3%
20.7%

Scores and fair valueIndustry

Graham Number
$27.57
$19.07
Graham Upside
-44.6%
-47.9%
Altman Z-Score
4.06
0.22
Piotroski F-Score
8
4
Beneish M-Score
-2.60
-2.62

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?